Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2
- PMID: 12874227
- DOI: 10.4049/jimmunol.171.3.1369
Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2
Abstract
The MHC class Ib molecule HLA-E is the primary ligand for CD94/NKG2A-inhibitory receptors expressed on NK cells, and there is also evidence for TCR-mediated recognition of this molecule. HLA-E preferentially assembles with a homologous set of peptides derived from the leader sequence of class Ia molecules, but its capacity to bind and present other peptides remains to be fully explored. The peptide-binding motif of HLA-E was investigated by folding HLA-E in vitro in the presence of peptide libraries derived from a nonameric leader peptide sequence randomized at individual anchor positions. A high degree of selectivity was observed at four of five total anchor positions, with preference for amino acids present in HLA-E-binding peptides from class Ia leader sequences. Selectivity was also observed at the nonanchor P5 position, with preference for positively charged amino acids, suggesting that electrostatic interactions involving the P5 side chain may facilitate assembly of HLA-E peptide complexes. The observed HLA-E peptide-binding motif was strikingly similar to that previously identified for the murine class Ib molecule, Qa-1. Experiments with HLA-E tetramers bearing peptides substituted at nonanchor positions demonstrated that P5 and P8 are primary contact residues for interaction with CD94/NKG2 receptors. A conservative replacement of Arg for Lys at P5 completely abrogated binding to CD94/NKG2. Despite conservation of peptide-binding specificity in HLA-E and Qa-1, cross-species tetramer-staining experiments demonstrated that the interaction surfaces on CD94/NKG2 and the class Ib ligands have diverged between primates and rodents.
Similar articles
-
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.EMBO J. 1999 Aug 2;18(15):4250-60. doi: 10.1093/emboj/18.15.4250. EMBO J. 1999. PMID: 10428963 Free PMC article.
-
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869. Nature. 1998. PMID: 9486650
-
Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.J Exp Med. 2000 Sep 4;192(5):613-24. doi: 10.1084/jem.192.5.613. J Exp Med. 2000. PMID: 10974028 Free PMC article.
-
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.Curr Pharm Des. 2009;15(28):3336-44. doi: 10.2174/138161209789105207. Curr Pharm Des. 2009. PMID: 19860683 Review.
-
Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.Microbes Infect. 2000 Apr;2(4):371-80. doi: 10.1016/s1286-4579(00)00330-0. Microbes Infect. 2000. PMID: 10817639 Review.
Cited by
-
Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.Sci Rep. 2016 Oct 31;6:36064. doi: 10.1038/srep36064. Sci Rep. 2016. PMID: 27796368 Free PMC article.
-
What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes.Front Pharmacol. 2022 Aug 4;13:925427. doi: 10.3389/fphar.2022.925427. eCollection 2022. Front Pharmacol. 2022. PMID: 35991867 Free PMC article.
-
CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.J Exp Med. 2008 Mar 17;205(3):725-35. doi: 10.1084/jem.20072525. Epub 2008 Mar 10. J Exp Med. 2008. PMID: 18332182 Free PMC article.
-
NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes.Hum Immunol. 2005 Dec;66(12):1223-34. doi: 10.1016/j.humimm.2006.02.005. Epub 2006 Mar 27. Hum Immunol. 2005. PMID: 16690409 Free PMC article.
-
Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.J Immunol. 2020 Nov 15;205(10):2861-2872. doi: 10.4049/jimmunol.2000810. Epub 2020 Oct 5. J Immunol. 2020. PMID: 33020145 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous